406 related articles for article (PubMed ID: 24628407)
1. Cases with a spontaneous regression of an infiltrating non-crateriform keratoacanthoma and squamous cell carcinoma with a keratoacanthoma-like component.
Misago N; Takai T; Murata Y; Nagase K; Narisawa Y
J Dermatol; 2014 May; 41(5):430-4. PubMed ID: 24628407
[TBL] [Abstract][Full Text] [Related]
2. Natural course of keratoacanthoma and related lesions after partial biopsy: clinical analysis of 66 lesions.
Takai T; Misago N; Murata Y
J Dermatol; 2015 Apr; 42(4):353-62. PubMed ID: 25676096
[TBL] [Abstract][Full Text] [Related]
3. Keratoacanthoma and other types of squamous cell carcinoma with crateriform architecture: classification and identification.
Misago N; Inoue T; Koba S; Narisawa Y
J Dermatol; 2013 Jun; 40(6):443-52. PubMed ID: 23414327
[TBL] [Abstract][Full Text] [Related]
4. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
[TBL] [Abstract][Full Text] [Related]
5. Solitary keratoacanthoma: a self-healing proliferation that frequently becomes malignant.
Sánchez Yus E; Simón P; Requena L; Ambrojo P; de Eusebio E
Am J Dermatopathol; 2000 Aug; 22(4):305-10. PubMed ID: 10949454
[TBL] [Abstract][Full Text] [Related]
6. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
Corbalán-Vélez R; Martínez-Barba E; López-Poveda MJ; Vidal-Abarca Gutiérrez I; Ruíz-Maciá JA; Oviedo-Ramirez I; Martínez-Menchón T
Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864
[TBL] [Abstract][Full Text] [Related]
7. What Is a Solitary Keratoacanthoma? A Benign Follicular Neoplasm, Frequently Associated with Squamous Cell Carcinoma.
Ogita A; Ansai SI
Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679546
[TBL] [Abstract][Full Text] [Related]
8. Crater/ulcerated form of infundibular squamous cell carcinoma: A possible distinct entity as a malignant (or high-grade) counterpart to keratoacanthoma.
Misago N; Inoue T; Nagase K; Tsuruta N; Tara-Hashimoto A; Kimura H; Takahara K; Narita T; Narisawa Y
J Dermatol; 2015 Jul; 42(7):667-73. PubMed ID: 25854192
[TBL] [Abstract][Full Text] [Related]
9. Perforating elastic fibers ('elastic fiber trapping') in the differentiation of keratoacanthoma, conventional squamous cell carcinoma and pseudocarcinomatous epithelial hyperplasia.
Shah K; Kazlouskaya V; Lal K; Molina D; Elston DM
J Cutan Pathol; 2014 Feb; 41(2):108-12. PubMed ID: 24138600
[TBL] [Abstract][Full Text] [Related]
10. Possible spontaneous regression of a metastatic lesion of keratoacanthoma-like squamous cell carcinoma in a regional lymph node.
Ansai S; Manabe M
J Dermatol; 2005 Nov; 32(11):899-903. PubMed ID: 16361751
[TBL] [Abstract][Full Text] [Related]
11. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases.
Cribier B; Asch P; Grosshans E
Dermatology; 1999; 199(3):208-12. PubMed ID: 10592399
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
[TBL] [Abstract][Full Text] [Related]
13. Keratoacanthoma centrifugum marginatum versus low-grade squamous cell carcinoma.
Peteiro MC; Caeiro JL; Toribio J
Dermatologica; 1985; 170(5):221-4. PubMed ID: 4007216
[No Abstract] [Full Text] [Related]
14. Keratoacanthoma en plaque/nodule: A brief report of the clinicopathological features of five cases.
Misago N; Ansai SI; Fukumoto T; Anan T; Nakao T
J Dermatol; 2017 Jul; 44(7):803-807. PubMed ID: 28332728
[TBL] [Abstract][Full Text] [Related]
15. Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients.
Cabibi D; Aragona F; Guarnotta C; Rodolico V; Zerilli M; Belmonte B; Schillaci L; Aragona F
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):239-45. PubMed ID: 21475039
[TBL] [Abstract][Full Text] [Related]
16. Keratoacanthoma: clinical and histopathologic features of regression.
Ko CJ; McNiff JM; Bosenberg M; Choate KA
J Am Acad Dermatol; 2012 Nov; 67(5):1008-12. PubMed ID: 22521202
[TBL] [Abstract][Full Text] [Related]
17. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
18. [Keratoacanthoma of the lower lip. A review of the literature and clinical case report].
Berrone S; De Gioanni PP; Gallesio C
Minerva Stomatol; 1992 Dec; 41(12):597-601. PubMed ID: 1301495
[TBL] [Abstract][Full Text] [Related]
19. CD30+ cells in regressing keratoacanthoma and in non-keratoacanthomatous squamous cell carcinoma.
Fernandez-Flores A
Bratisl Lek Listy; 2008; 109(11):508-12. PubMed ID: 19205562
[TBL] [Abstract][Full Text] [Related]
20. Keratoacanthoma of the inferior lip: review and report of case with spontaneous regression.
Ramos LM; Cardoso SV; Loyola AM; Rocha MA; Durighetto-Júnior AF
J Appl Oral Sci; 2009; 17(3):262-5. PubMed ID: 19466263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
